On the occasion of the BIO-Europe Spring 2017 event in Barcelona, the newspaper “La Vanguardia” has published an article about the campaign to host the new headquarters of the London-based European Medicines Agency (EMA) after Brexit.
The article also includes a reference to the participation of IRB Barcelona’s Innovation Department in this three-day partnering conference for the biotechnology industry.
The 2017 Issue of the European Biotechnology magazine on the Life Sciences and Industry features recent studies conducted at IRB Barcelona by Oriol Gallego, research associate with the Translational Control of Cell Cycle and Differentiation Lab, and Salvador Aznar Benitah, ICREA researcher and group leader of the Stem Cells and Cancer Lab.
The magazines also includes a news piece about the research collaboration between Eduard Batlle's laboratory and the clinical-stage immuno-oncology company devoted to innovative bispecific antibody therapeutics Merus N.V., to develop antibodies targeting the tumour microenvironment.
The local newspaper “Diari de Girona” publishes an article about the discovery of a mechanism responsible for halting protein synthesis when cells are deprived of nutrients. This discovery has been made by researchers at the Consejo Superior de Investigaciones Científicas (CSIC) in Madrid and Salamanca and at IRB Barcelona.
Published in the journal eLife, the study paves the way to regulating cell growth and has clear implications for research into new treatments for cancer.
More than 200 regional, national and international media have echoed the research performed by IDIBAPS and IRB Barcelona scientists and recently published in Nature Communications.
In the study—co-led by Cristina Fillat, head of the Gene Therapy and Cancer Group at IDIBAPS, and Raúl Méndez, ICREA researcher at IRB Barcelona—they have designed a new strategy to achieve genetically modified viruses that selectively attack tumor cells without affecting healthy tissues.
Link to BTV
Other media mentions
Research into a small group of passive stem cells (quiescent), which are activated when needed and have the capacity to produce any kind of intestinal cell, has received a special mention on the Health Institute website of the Carlos Slim Foundation.
Published in Cell Stem Cell and headed by Eduard Batlle at IRB Barcelona, the study identifies a group of quiescent stem cells of the intestine that are relevant for tissue regeneration and for their participation in tumour development.
Several media have echoed the research project on Friedreich’s Ataxia at IRB Barcelona, funded by the associations of patients and families called the Babel Family and the Asociación Granadina de la Ataxia de Friedreich (ASOGAF), for the initial 18 months.
The project aims to develop an injectable frataxin treatment that can reach the brain. Frataxin is the protein that is reduced in those affected by this rare and degenerative disease, which has no cure.
The Asociación Española Contra el Cáncer (Spanish Association against Cancer)(AECC) presents its WIN.0 non-alcoholic wine to support an IRB Barcelona project undertaken by Jelena Urosevic, a postdoctoral fellow with the Growth Control and Cancer Metastasis Laboratory.
The project seeks to identify those phosphatases that are regulated by the metastatic process in colon cancer.
Link to Win-zero
The Generalitat’s (Catalan Government) Universities and Research website has echoed on the research performed by scientists at IRB Barcelona and the UB, namely a shuttle produced from a peptide present in bee venom and capable of transporting molecules into the brain.
The research results arose from the Benjamí Oller's PhD thesis, done in Professor Ernest Giralt's Lab at IRB Barcelona and defended in 2015. In January 2016, he started his postdoctoral training in Cambridge, UK.
Link to Universities and...
The newspaper "AraBalears" interviews Eduard Batlle, coordinator of IRB Barcelona’s Oncology Programme and ICREA researcher, on the effectiveness of immunotherapies to treat metastatic disease in advanced colorectal cancer.
Link to AraBalears
EFE Agency and other media have echoed the research performed by scientists at IRB Barcelona headed by ICREA researcher Eduard Batlle, leader of the Colorectal Cancer Laboratory. The first author is Francisco Barriga, current postdoctoral fellow at Memorial Sloan Kettering Cancer Center in New York.
Published in Cell Stem Cell, the study identifies a new group of intestinal stem cells with very different characteristics to those of the abundant and active stem cells already known in this organ. It is a small group of passive stem cells—quiescent. These cells are activated when needed, such as in situations of stress, like after chemotherapy, in inflammatory processes, and in...